Euro biotechs eye paths to Wall Street; Valeant cutting 258 Salix jobs;

@FierceBiotech: ICYMI: GlaxoSmithKline to create new vaccines hub, uprooting groups in Cambridge, Philly. Report | Follow @FierceBiotech

@JohnCFierce: You rarely see a real battle to the death in biotech over patents. Usually, it all gets down to a reasonable set of numbers. | Follow @JohnCFierce

> European biotech companies are increasingly allured by the prospect of going public in the U.S., swayed by comparative optimism and favorable regulations. Item

> Valeant ($VRX) has begun cutting staff at Salix Pharmaceuticals, its latest acquisition. The company is eyeing 258 layoffs as part of an effort to save $500 million. News

Medical Device News

@FierceMedDev: Check out the top med tech companies of 2014. Feature | Follow @FierceMedDev

@StacyALawrence: ICYMI: FDA to investigate Bayer's birth control device after allegations of trial fraud. Story | Follow @StacyALawrence

@VarunSaxena2: ICYMI: Medtronic tries again in renal denervation after previous trial failure. Article | Follow @VarunSaxena2

@EmilyWFierce: Medtronic grabs artificial pancreas tech from Israeli devicemaker. Report | Follow @EmilyWFierce

> U.S. health insurers consider new curbs on morcellators amid regulatory pushback. Article

> Medtronic pays feds $4.4 million over DOJ allegations that it falsely labeled devices as made in the USA. Story

Pharma News

@FiercePharma: What's Next For The Thousands Of Angry Men Suing Over Testosterone? Forbes article | Follow @FiercePharma

@CarlyHFierce: ICYMI: Pfizer shutters vaccine sales business in China after Prevenar setback. Story | Follow @CarlyHFierce

> Valeant starts $500M in Salix cost-cutting with 250 layoffs. Article

> Amgen CEO Bradway collects a $14M pay package on record-breaking revenue. Report

Animal Health News

> TVAX pours $2M funding round into canine osteosarcoma drug. More

> UN launches global campaign to wipe out ruinous sheep and goat virus. Article

> Under pressure, Zoetis pulls arsenic-based poultry drug from market. News

> Homeland Security names program manager for new NBAF facility in Kansas. Story

> Texas Tech scientists discover that antibiotic-resistant bugs from cattle lots are airborne. Report

Biotech IT News

> Celgene, Genentech back clinical trial enrollment challenge. News

> Potency prediction software helps Schrödinger land $120M Sanofi deal. Report

> Genentech begins search for bioinformatics chief after Gentleman leaves for 23andMe. Story

> 23andMe-style sequencing project taps Facebook in pursuit of 20,000 participants. Article

> Genome Canada makes $24M pivot to bolster bioinformatics capabilities. More

Suggested Articles

When thinking about clinical research patient recruitment, a crucial step is building effective patient recruitment advertising campaigns.

Novavax delayed the start of a large phase 3 trial for its COVID-19 vaccine in the U.S. and Mexico, thanks to delays in scaling up manufacturing.

The decision to dump IL33r antagonist GSK3772847 follows lackluster clinical data on rival candidates against the same target.